10x Genomics
TXG
#2484
Rank
A$10.73 B
Marketcap
A$81.61
Share price
-5.50%
Change (1 day)
239.59%
Change (1 year)

10x Genomics (TXG) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : A$0.30 Billion

According to 10x Genomics 's latest financial reports the company's total liabilities are A$0.30 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

10x Genomics - Total liabilities on balance sheet (from 2018 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$0.36 B9.14%
2024-12-31A$0.33 B1.91%
2023-12-31A$0.32 B0.27%
2022-12-31A$0.32 B18.17%
2021-12-31A$0.27 B12.19%
2020-12-31A$0.24 B-6.78%
2019-12-31A$0.26 B-45.69%
2018-12-31A$0.48 B102.83%
2017-12-31A$0.24 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Organovo
ONVO
A$6.17 M-97.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
A$0.18 B-40.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
A$1.70 B 460.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
A$0.67 B 123.50% Jersey